Filing Details
- Accession Number:
- 0000899243-21-002905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-22 16:05:09
- Reporting Period:
- 2021-01-20
- Accepted Time:
- 2021-01-22 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1797336 | Ayala Pharmaceuticals Inc. | AYLA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1647053 | Roni Mamluk | Oppenheimer 4 Rehovot L3 7670104 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-20 | 19,466 | $15.03 | 179,877 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-21 | 1,406 | $15.04 | 178,471 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.